42 search results for ‘*’
07/09/2021 | Stephanie Vine
A breakthrough in transgenic mice opens the door to “Humabodies.”
12/09/2019 | Jonathan James
How strong partnerships can drive early-phase clinical trials
07/23/2019
Sitting Down With… Mike Clayman, CEO of Flexion Therapeutics, Inc., Burlington, Massachusetts, USA.
07/12/2019 | Jonathan James
Sitting Down with Michael Tanner, Research Fellow in the School of Engineering and Physical Sciences at Heriot Watt University, Edinburgh, UK.
04/11/2019 | Jonathan James
The publication of over 100 genetic markers associated with depression has rocked the neuroscience community.
04/03/2019 | Luke Turner
We sit down with England’s Chief Scientific Officer, Professor Dame Sue Hill, to learn how genomics will influence the future of pathology.
03/19/2019 | Jonathan James
Three leading lights in the neuro-oncology sphere explain what inspired them, how the field has evolved, and what challenges lie ahead.
02/06/2019 | Jonathan James
How a 3D-printed chemical absorber could pave the way for higher chemotherapy doses – or lower risks.
01/25/2019 | Jonathan James
Harvard Medical School’s Richard Sherwood digs into the potential and pitfalls of gene editing technology.
01/24/2019 | James Strachan
Sitting Down With... Bruce Levine, Professor in Cancer Gene Therapy, Perelman School of Medicine, University of Pennsylvania.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
You will benefit from:
Register
Express Insight into Bladder Cancer
Changing the Leopard’s Spots
Making It (Im)personal